Sign up
Pharma Capital

WideCells opens up its Manchester HQ and laboratory to Proactive Investors

WideCells Group PLC (LON:WDC) chief executive Joao Andrade and chief scientific officer Dr Peter Hollands give Proactive a tour of their headquarters and laboratory at the University of Manchester Innovation Centre.

Dr Hollands also gives us an exclusive look at their Cryogenics section - where they store stem cells for future use.

 

View full WDC profile

WideCells Group Timeline

Newswire

WideCells expands its reach to Spain

View All

© biotech Capital 2017

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.